Infektio Research GmbH & Co. KG — Clinical Trial Site

12 Registered trials

1 Currently recruiting

Organisation

Infektio Research GmbH & Co. KG

Location

Frankfurt Am Main, Germany

Identifier

ORG-100043176

Address

Stresemannallee 3, Sachsenhausen, 60596, Germany

Departments

DE011
Infektio Research GmbH & Co. KG
Infektio Research GmbH & Co.KG
Infektiologie
Infektiologikum
Infektiology
n/a
NA

Clinical trials at this site (12)

Search interface

A clinical study of people with HIV‐1 who switch their treatment to a combination of doravirine and islatravir Not authorised

2022-502079-49-00 HIV-1 infection 5
A clinical study of people with HIV-1 who received prior treatment combination of doravirine and islatravir Not authorised

2022-502126-40-00 HIV-1 infection 5
Safety and immunologic response of SHIngrix VAccination in patients suffering from Psoriasis or Psoriatic arthritis Recruiting

2024-512881-32-00 Psoriasis vulgaris and/or psoriatric arthritis 6 2023-11-22
PH 3b, CAB + RPV in people with suboptimal response to oral ART (CROWN) Ended

2024-515070-28-00 HIV Infections 5 2024-12-23
Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen Ended

2022-500929-33-01 Human Immunodeficiency Virus (HIV-1) infection 10 2023-05-17
Efficacy, immunogenicity, and safety of the 9vHPV vaccine in adult males 20 to 45 years of age Ended

2022-501974-21-00 Prevention of oral persistent infection caused by any o 5 2020-04-01
Study to Evaluate the Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide (F/TAF) Fixed-Dose Combination Once Daily for Pre-Expos… Ended

2022-501763-40-00 Pre-Exposure Prophylaxis of HIV-1 Infection 5 2016-12-13
A Study to Investigate the Safety, Efficacy, and Immunogenicity of mRNA-1010 Candidate Influenza Vaccine Compared with a Licensed Influenza … Ended

2024-516240-26-00 Influenza 5 2024-10-11
A study on the reactogenicity, safety, immune response, and efficacy of a targeted immunotherapy against HSV in healthy participants aged 18… Ended

2024-510571-37-00 Herpes Simplex 7 2023-12-06
Safety and efficacy of GSK Neisseria gonorrhoeae GMMA (NgG) investigational vaccine when administered to healthy adults 18 to 50 years of ag… Ended

2022-500883-37-00 This FTiH-PoC study aims to provide an early evaluation 7 2023-10-02
Phase 3 Study of Bepirovirsen in Nucleos(t)ide Analogue-treated Participants with Chronic Hepatitis B (B-Well 2) Ended

2023-504238-23-00 Hepatitis B, Chronic 5 2023-01-17
Safety and Immunogenicity of V116 in Adults 50 Years of Age or Older Ended

2022-503144-40-00 Pneumococcal disease 5 2022-11-17